13F Holdings
中文EN

MDAI Spectral AI, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1833498 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-37.6%
TTM net income YoY37.7%
TTM EPS YoY60.0%
Revenue 3-yr CAGR-8.5%
Net income 3-yr CAGR—

Margins

Gross margin39.9%
Operating margin-86.5%
Net margin-70.5%
FCF margin—
EBITDA margin-85.7%

Returns

ROE—
ROA-64.0%
ROIC (approx.)—
Asset turnover0.91x

Leverage & solvency

Liabilities / assets193.2%
Debt / equity—
Current ratio0.63x
Interest coverage-6.86x

Cash quality & payout

Operating cash flow / net income1.28x
Accruals ratio17.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$19.65M$29.58M$18.06M$25.37M—
Cost of revenue$10.72M$16.31M$10.18M$14.53M—
Gross profit$8.93M$13.27M$7.88M$10.84M—
R&D expense——$15.10M$16.50M—
SG&A expense$17.53M$19.86M$20.86M$13.48M$3.42M
Operating income-$8.60M-$6.58M-$12.98M-$2.65M-$3.42M
Interest expense$886,000-$14,000———
Pretax income-$7.56M-$15.04M-$20.84M-$2.81M-$2.15M
Income tax$11,000$114,000$11,000$106,000$0
Net income-$7.57M-$15.16M-$20.85M-$2.91M-$2.15M
EBITDA-$8.53M-$6.57M-$12.97M-$2.64M—
EPS (basic)-0.29-0.85-1.48-0.22—
EPS (diluted)-0.29-0.85-1.48-0.22—
Weighted avg. shares (diluted)26.52M17.93M14.09M13.14M—
Banking
Net interest income———$12.90M$1.27M
Balance sheet
Cash & equivalents$15.40M$5.16M$4.79M$14.17M$16.12M
Receivables$1.27M$2.50M$2.35M$2.29M—
Inventory$838,000$425,000$230,000——
Current assets$19.45M$10.12M$9.90M$17.69M$1.08M
PP&E, net$258,000$2,000$12,000$21,000—
Total assets$21.41M$12.10M$10.69M$18.72M$254.11M
Current liabilities$20.63M$17.64M$12.40M$6.37M$2.94M
Long-term debt$5.54M$2.79M———
Total debt$5.54M$2.79M———
Total liabilities$27.13M$19.35M$12.40M$6.72M$21.93M
Shareholders' equity-$5.73M-$7.25M-$2.15M$12.00M$13.75M
Net debt-$9.86M-$2.37M———
Shares outstanding30.69M22.59M16.29M13.17M—
Cash flow statement
Operating cash flow-$9.92M-$9.20M-$13.24M-$1.16M-$825,593
Investing cash flow———$251.56M-$253.00M
Financing cash flow$20.12M$9.57M$3.84M-$785,000$254.60M
Depreciation & amortization$71,000$10,000$9,000$11,000—
Stock-based compensation$1.11M$1.03M$1.24M$1.16M—
Share buybacks———$250.52M$0

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.